ARBOR PHARMACEUTICALS
Live / Registered — Registered and renewed (as of 05 Oct 2021)
What this means for you
Registered since 22 May 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 May 2022).
Record
- Serial number
- 85427281
- Registration number
- 4146108
- Mark type
- Stylized text
- Filed
- 20 Sept 2011
- Published for opposition
- 06 Mar 2012
- Registered
- 22 May 2012
- Next maintenance due
- 22 May 2022
- Attorney of record
- Elizabeth M. Fox
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- ARBOR PHARMACEUTICALS, LLC, ATLANTA, GA, US
- Arbor Pharmaceuticals, Inc., Atlanta, GA, US
- Arbor Pharmaceuticals, Inc., Atlanta, GA, US
- Arbor Pharmaceuticals, Inc., Atlanta, GA, US
Prosecution history
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Oct 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 05 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 May 2021 — TEAS SECTION 8 & 9 RECEIVED
- 22 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Jul 2018 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 17 May 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 17 May 2018 — POST REGISTRATION ACTION MAILED - SEC. 7
- 15 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 May 2018 — OTQR WITHDRAWAL FROM PUBLICATION
- 11 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 May 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL